Results 151 to 160 of about 172,497 (260)

Rational design of Ni‐based catalysts for methane dry reforming: Recent advances and future perspectives

FlexMat, EarlyView.
Addressing the challenges inherent in dry reforming of methane (DRM), this paper focuses on the structural design and performance optimization of Ni‐based catalysts. The modulation strategies for DRM are systematically reviewed across four dimensions: the micromorphology of active metals, metal‐support interactions, electronic modifications by ...
Bowei Cao, Junlei Zhang, Wanglei Wang
wiley   +1 more source

Correction to: Multimodal positron emission tomography (PET) imaging in non-oncologic musculoskeletal radiology. [PDF]

Skeletal Radiol
Kogan F, Yoon D, Teeter MG, Chaudhari AJ, Hales L, Barbieri M, Gold GE, Vainberg Y, Goyal A, Watkins L.   +9 more
europepmc   +1 more source

Comparison of In‐Office and General Anesthesia Biopsies for Oropharyngeal Squamous Cell Carcinoma in a Public Healthcare System

Head &Neck, EarlyView.
ABSTRACT Background We compared treatment delays, costs, and management impact between oropharyngeal squamous cell carcinoma (OPSCC) patients undergoing in‐office versus general anesthesia panendoscopy‐guided biopsies in two large tertiary centers in a public healthcare system. Methods All OPSCC patients included were treated between 2010 and 2024 with
Samuel Bellavance, Michel Khoury, Justine Colivas, Jonathan Primiani, Gabriel Dayan, Eric Bissada, Tareck Ayad, Apostolos Christopoulos, Jean‐Claude Tabet, Louis Guertin, Paul Tabet   +10 more
wiley   +1 more source

Value of 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) in the Detection of Recurrence in Medullary Thyroid Carcinoma With Negative Conventional Imaging: A Case Report. [PDF]

Cureus
Gutierrez Albenda D, Murillo Jiménez J, Rodríguez Varela LN, Ulate Blanco P, Sánchez Hidalgo NM.   +4 more
europepmc   +1 more source

Visualization of Scattered Tumor Regression Following Neoadjuvant Chemoimmunotherapy With a Novel Intraoperative PET/CT Scanner

Head &Neck, EarlyView.
ABSTRACT Background Neoadjuvant chemoimmunotherapy is being explored in locally advanced head and neck squamous cell carcinoma (HNSCC), yet the spatial patterns of pathologic response and clinical implications remain poorly characterized. Methods A 79‐year‐old female with recurrent left oral tongue SCC (PD‐L122C3 Combined Positive Score 90) who ...
Andreja Radevic, Joaquin Austerlitz, Ashtyn McAdoo, Kyrionna Golliday, Takeshi Takahashi, Mitra Mehrad, Adam J. Rosenberg, Barbara A. Murphy, Eben Rosenthal, Michael C. Topf   +9 more
wiley   +1 more source

Test-retest properties of [¹¹C]PXT012253 as a positron emission tomography (PET) radiotracer in healthy human brain: PET imaging of mGlu4. [PDF]

EJNMMI Res
Stenkrona P, Arakawa R, Guo J, Bang-Andersen B, Nag S, Moein MM, Jia Z, Cselenyi Z, Halldin C, Varrone A.   +9 more
europepmc   +1 more source

Early Feasibility of Registration of Micro‐PET/CT Scans to Annotated 3D Specimen Models

Head &Neck, EarlyView.
ABSTRACT Background Intraoperative 18F‐fluorodeoxyglucose (18F‐FDG) micro‐positron emission tomography/computed tomography (micro‐PET/CT) is an emerging modality for margin assessment. Prior to clinical use, micro‐PET/CT margin distances must be correlated with gold‐standard histopathology.
Joaquin Austerlitz, Andreja Radevic, Ashtyn McAdoo, Kyrionna Golliday, Cheng Ye, Daniel Fabbri, Adam J. Rosenberg, Marcus Balanky, Anas Alabkaa, Kim A. Ely, Mitra Mehrad, Spencer Roark, Eben Rosenthal, Michael C. Topf   +13 more
wiley   +1 more source

Contemporary Role of Positron Emission Tomography (PET) in Endocarditis: A Narrative Review. [PDF]

J Clin Med
Sammartino AM, Bonfioli GB, Dondi F, Riccardi M, Bertagna F, Metra M, Vizzardi E.   +6 more
europepmc   +1 more source

Tumor‐Regional Immune Microenvironment: A Critical Factor in the Design of Radiotherapy–Immunotherapy Combination Trials

International Journal of Cancer, EarlyView.
ABSTRACT Clinical trials combining radiotherapy (RT) with immune checkpoint blockade (ICB) have shown improved outcomes in only a fraction of patients, and optimal strategies for integrating these modalities remain under intense investigation. With a few exceptions, phase III combination trials have yielded disappointing results.
Xuanwei Zhang, Hui Wang, Weiyan Tang, Kai Kang, Kateryna Onyshchenko, Taotao Huang, Dan Liu, Jianxin Xue, You Lu, Gabriele Niedermann, Ren Luo   +10 more
wiley   +1 more source

Development of Carbon-11 Labeled Pyrimidine Derivatives as Novel Positron Emission Tomography (PET) Agents Enabling Brain Sigma-1 Receptor Imaging. [PDF]

Adv Sci (Weinh)
Bai P, Gomm A, Yoo CH, Mondal P, Lobo FM, Meng H, Zhou Y, Xie W, Wey HY, Tanzi RE, Zhang C, Wang C, Lan Y.   +12 more
europepmc   +1 more source